Your browser doesn't support javascript.
loading
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Liu, Jingjing; Prager-van der Smissen, Wendy J C; Collée, J Margriet; Bolla, Manjeet K; Wang, Qin; Michailidou, Kyriaki; Dennis, Joe; Ahearn, Thomas U; Aittomäki, Kristiina; Ambrosone, Christine B; Andrulis, Irene L; Anton-Culver, Hoda; Antonenkova, Natalia N; Arndt, Volker; Arnold, Norbert; Aronson, Kristan J; Augustinsson, Annelie; Auvinen, Päivi; Becher, Heiko; Beckmann, Matthias W; Behrens, Sabine; Bermisheva, Marina; Bernstein, Leslie; Bogdanova, Natalia V; Bogdanova-Markov, Nadja; Bojesen, Stig E; Brauch, Hiltrud; Brenner, Hermann; Briceno, Ignacio; Brucker, Sara Y; Brüning, Thomas; Burwinkel, Barbara; Cai, Qiuyin; Cai, Hui; Campa, Daniele; Canzian, Federico; Castelao, Jose E; Chang-Claude, Jenny; Chanock, Stephen J; Choi, Ji-Yeob; Christiaens, Melissa; Clarke, Christine L; Couch, Fergus J; Czene, Kamila; Daly, Mary B; Devilee, Peter; Dos-Santos-Silva, Isabel; Dwek, Miriam; Eccles, Diana M; Eliassen, A Heather.
Afiliação
  • Liu J; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Prager-van der Smissen WJC; Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
  • Collée JM; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Bolla MK; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ahearn TU; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Aittomäki K; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Ambrosone CB; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Anton-Culver H; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Antonenkova NN; Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Arndt V; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Arnold N; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Aronson KJ; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
  • Augustinsson A; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Auvinen P; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Becher H; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Beckmann MW; Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Behrens S; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON, Canada.
  • Bermisheva M; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
  • Bernstein L; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
  • Bogdanova NV; Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland.
  • Bogdanova-Markov N; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
  • Bojesen SE; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Brauch H; Institute of Biometry and Clinical Epidemiology, Charité -Universitätsmedizin Berlin, Berlin, Germany.
  • Brenner H; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Briceno I; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brucker SY; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  • Brüning T; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Burwinkel B; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  • Cai Q; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  • Cai H; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Campa D; Institute of Human Genetics, University of Münster, Münster, Germany.
  • Canzian F; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Castelao JE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Chang-Claude J; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Chanock SJ; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Choi JY; iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.
  • Christiaens M; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.
  • Clarke CL; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Couch FJ; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Czene K; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
  • Daly MB; Medical Faculty, Universidad de La Sabana, Bogota, Colombia.
  • Devilee P; Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany.
  • Dos-Santos-Silva I; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
  • Dwek M; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Eccles DM; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
  • Eliassen AH; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Sci Rep ; 10(1): 9688, 2020 06 16.
Article em En | MEDLINE | ID: mdl-32546843
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mutação em Linhagem Germinativa / Proteínas de Homeodomínio Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mutação em Linhagem Germinativa / Proteínas de Homeodomínio Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda